2
Clinical Trials associated with HRS-5632 / Not yet recruitingPhase 2 A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of HRS-5632 Injection in Adult Patients at High Risk of Cardiovascular Events With Elevated Lipoprotein(a)
The main purpose of this study is to evaluate the efficacy and safety of HRS-5632 in adult participants with elevated Lipoprotein(a) (Lp(a)) at high risk for cardiovascular events.
/ Active, not recruitingPhase 1 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Subcutaneous Injection of HRS-5632 in Healthy Subjects - A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Study
The study is being conducted to evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of HRS-5632 Following a Single Subcutaneous Injection in Healthy Subjects
100 Clinical Results associated with HRS-5632
100 Translational Medicine associated with HRS-5632
100 Patents (Medical) associated with HRS-5632
100 Deals associated with HRS-5632